扣非后净利润同比增长 57.07%，在建项目进展顺利 星湖科技(600866) ——星湖科技 2024 年&2025Q1 点评 股票研究 /[Table_Date] 2025.04.30 2025-05-09 [Table_Market] 交易数据 本报告导读： 公司 2024 年实现扣非后净利润 11.42 亿元，同比增长 57.07%，主要受益于产品销量 大幅增加；公司预计派发现金红利总额占归母净利润比例为 66.94%。 投资要点： | [Table_Finance] 财务摘要（百万元） | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业收入 | 17,374 | 17,334 | 18,881 | 20,305 | 21,755 | | (+/-)% | -0.6% | -0.2% | 8.9% | 7.5% | 7.1% | | 净利润（归母） | 678 | 943 | 1,318 | 1,433 | 1,601 | | (+/-)% | 11.4% | 39.1% | 39.7% ...

业绩大幅增长，看好制冷剂景气周期 巨化股份(600160) ——巨化股份 2024 年报及 2025Q1 季报点评 [Table_Industry] 石油/能源 [Table_Invest] 评级： 增持 [Table_Target] 目标价格： 32.75 [Table_CurPrice] 当前价格： 25.41 [Table_Market] 交易数据 二代和三代制冷剂价格大幅上涨，公司 24 年业绩大幅增长。2025 年制冷剂配额政 策延续，叠加下游需求增长，公司作为三代制冷剂龙头将充分受益制冷剂景气周期。 投资要点： | [Table_Finance] 财务摘要（百万元） | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业收入 | 20,655 | 24,462 | 25,664 | 27,079 | 28,445 | | (+/-)% | -3.9% | 18.4% | 4.9% | 5.5% | 5.0% | | 净利润（归母） | 944 | 1,960 | 3,548 | 4,2 ...

扣非后净利润同比下降 14.17%，子公司获得探矿权 远兴能源(000683) ——远兴能源 2024 年年报点评 基础化工 [Table_Industry] /原材料 投资要点： | [Table_Finance] 财务摘要（百万元） | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业收入 | 12,044 | 13,264 | 11,779 | 14,287 | 16,243 | | (+/-)% | 9.6% | 10.1% | -11.2% | 21.3% | 13.7% | | 净利润（归母） | 1,410 | 1,811 | 1,432 | 1,879 | 2,345 | | (+/-)% | -47.0% | 28.5% | -20.9% | 31.2% | 24.8% | | 每股净收益（元） | 0.38 | 0.48 | 0.38 | 0.50 | 0.63 | | 净资产收益率(%) | 10.5% | 12.5% | 9.4% | 11.6% | 13.4% | | ...

Investment Rating - The report maintains an "Outperform" rating for the company [1][9]. Core Views - The company's profit in 2024 was significantly impacted by exchange rate losses, but channel expansion is progressing well. Revenue is expected to grow significantly in 2025, with an improved gross profit margin (GPM). There is optimism regarding increased profit flexibility from the European and American markets in 2025-2026. The earnings per share (EPS) forecasts for 2025-2027 are RMB 3.65, 4.83, and 5.95, respectively, with a 2025 price-to-earnings (PE) ratio of 20.0x, setting a target price of RMB 73.00 [1][9]. Financial Summary - In 2024, the company achieved revenue of RMB 13.30 billion, a year-on-year increase of 15.77%, while the net profit attributable to shareholders was RMB 450 million, a decrease of 41.63% year-on-year. The fourth quarter of 2024 saw revenue of RMB 3.51 billion, up 18.38% year-on-year, but down 14.44% quarter-on-quarter, with a net profit of RMB 109 million, up 119.23% year-on-year, but down 32.08% quarter-on-quarter [2][4][9]. - For the first quarter of 2025, the company reported revenue of RMB 2.69 billion, a slight decrease of 0.26% year-on-year and a 23.49% decrease quarter-on-quarter, with a net profit of RMB 257 million, reflecting a year-on-year increase of 67.98% and a quarter-on-quarter increase of 136.59% [4][9]. Business Development - The company focused on growing its direct-to-consumer (TO C) business in 2024, with the revenue share rising from 33.82% in 2023 to 37.65% in 2024. The GPM for the TO C business was 28.99%, an increase of 0.09% year-on-year. The share of revenue from the EU and North American markets increased from 5.69% in 2023 to 9.75% in 2024. Additionally, the revenue share from insecticides and fungicides rose from 25.41% in 2023 to 25.71% in 2024 [4][9]. - The company strengthened its biopharmaceutical segment by forming a global team, achieving first-year sales of approximately USD 10 million. In 2024, it obtained over 1000 new registrations, totaling over 7700 pesticide registrations by December 31, 2024, including new registrations in countries such as the USA, Canada, and Italy [4][9].

原材料涨价致业绩承压，拟建巴西项目基地 玲珑轮胎(601966) ——玲珑轮胎 2024 年报及 2025Q1 季报点评 本报告导读： 原材料涨价致 2025Q1 业绩承压，塞尔维亚项目产能快速爬坡中，兵器公司公告拟 投建巴西项目。公司将持续受益于中长期产能释放，配套和替换端发力。 投资要点： | [Table_Finance] 财务摘要（百万元） | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业收入 | 20,165 | 22,058 | 24,932 | 26,942 | 28,205 | | (+/-)% | 18.6% | 9.4% | 13.0% | 8.1% | 4.7% | | 净利润（归母） | 1,391 | 1,752 | 2,134 | 2,462 | 2,717 | | (+/-)% | 376.9% | 26.0% | 21.8% | 15.3% | 10.4% | | 每股净收益（元） | 0.95 | 1.20 | 1.46 | 1.68 | 1.86 | | ...

Investment Rating - The report maintains an "Outperform" rating for the company [4][8]. Core Views - The company's short-term performance is under pressure due to industry cost pressures and decreased production and sales. The EPS forecasts for 2025 and 2026 have been lowered to RMB 2.14 and RMB 2.57, respectively, with a new forecast for 2027 set at RMB 2.82. The target price has been reduced by 25% to RMB 25.68, applying a 12x PE for 2025 [4][8]. Financial Summary - For 2024, the company's revenue and net profit attributable to shareholders are projected to be RMB 8.51 billion and RMB 2.19 billion, representing year-on-year increases of 8.53% and 59.74%, respectively. The Q4 2024 revenue and net profit are expected to be RMB 2.17 billion and RMB 460 million, with year-on-year growth of 3.38% and 22.7% [4][8]. - In Q1 2025, the company is expected to report revenue and net profit attributable to shareholders of RMB 2.06 billion and RMB 361 million, reflecting year-on-year declines of 2.79% and 28.29% [4][8]. Production and Sales Performance - By the end of 2024, the company's tyre sector production and sales are expected to reach 32.23 million and 31.41 million units, respectively, with year-on-year increases of 10.22% and 7.34%. The revenue for this segment is projected at RMB 8.50 billion, up 8.57% year-on-year [4][8]. - In Q1 2025, tyre sector production and sales are expected to decline to 7.92 million and 7.38 million units, with year-on-year decreases of 1.87% and 3.02% [4][8]. Strategic Developments - The company's "833plus" strategy is progressing steadily, with the Morocco project expected to achieve large-scale production in 2025. This project aims to produce 12 million high-performance tyres annually, enhancing the company's global competitiveness and profitability [4][8]. - The company has established a strong presence in the replacement market, with over 5% market share in the USA and over 4% in Europe for its tyre products in 2024. It is also recognized as a qualified supplier for several major automotive manufacturers [4][8].

[Table_Title] 研究报告 Research Report 8 May 2025 米高集团 Migao Group (9879 HK) xh.sun@htisec.com [Table_yemei1] 热点速评 Flash Analysis [Table_summary] (Please see APPENDIX 1 for English summary) [Table_yejiao1] 本研究报告由海通国际分销，海通国际是由海通国际研究有限公司，海通证券印度私人有限公司，海通国际株式会社和海通国 际证券集团其他各成员单位的证券研究团队所组成的全球品牌，海通国际证券集团各成员分别在其许可的司法管辖区内从事证 券活动。关于海通国际的分析师证明，重要披露声明和免责声明，请参阅附录。(Please see appendix for English translation of the disclaimer) 公司是中国钾肥行业领先企业，通过进口途径采购氯化钾。米高集团成立于 2003 年 6 月，于 2024 年 3 月在 港交所主板上市。 公司主要从事钾肥产品的生产、加工和销售，具体产品包括氯化钾、硫 ...

[Table_Title] 研究报告 Research Report 8 May 2025 安道麦 Adama (000553 CH) 25Q1 净利润扭亏为盈，北美区业务呈现增长 Net Profit turned loss into profit in 25Q1, North American business achieves growth. 孙小涵 Xiaohan Sun xh.sun@htisec.com [Table_yemei1] 热点速评 Flash Analysis [Table_summary] (Please see APPENDIX 1 for English summary) [Table_yejiao1] 本研究报告由海通国际分销，海通国际是由海通国际研究有限公司，海通证券印度私人有限公司，海通国际株式会社和海通国 际证券集团其他各成员单位的证券研究团队所组成的全球品牌，海通国际证券集团各成员分别在其许可的司法管辖区内从事证 券活动。关于海通国际的分析师证明，重要披露声明和免责声明，请参阅附录。(Please see appendix for English translation ...

Investment Rating - The report maintains an "Outperform" rating for the company and raises the target price to RMB 56.67 from the previous estimate [5][11]. Core Insights - The company reported strong export performance and continuous growth in new products, particularly in the enterprise network segment, which saw revenue doubling [6][12]. - For 2024, the company achieved revenue of RMB 612 million, a year-on-year increase of 24.00%, and a net profit attributable to shareholders of RMB 130 million, up 38.25% year-on-year [11][12]. - The first quarter of 2025 showed revenue of RMB 150 million, reflecting a 40.86% year-on-year growth, primarily driven by overseas market expansion and early stocking by some U.S. clients [11][12]. Financial Summary - Revenue projections for 2025-2027 are RMB 749 million, RMB 885 million, and RMB 1,016 million, respectively, with corresponding net profits of RMB 167 million, RMB 214 million, and RMB 261 million [4][11]. - The earnings per share (EPS) are expected to be RMB 2.27, RMB 2.90, and RMB 3.53 for 2025, 2026, and 2027, respectively [4][11]. - The company’s gross profit margin (GPM) for various products shows strong performance, with industrial IoT products at 56.73% and enterprise network products at 55.65% [12]. Product and Market Performance - By product, industrial IoT revenue was RMB 314 million (YoY +28.49%), enterprise network revenue was RMB 77.08 million (YoY +94.90%), and overseas market revenue reached RMB 274 million (YoY +53.63%) [12][13]. - The company has announced a restricted stock incentive plan for 2025, indicating confidence in long-term growth, with performance targets set for revenue growth of not less than 15%, 32.25%, and 52.09% for 2025-2027 [13][14].

Investment Rating - The report maintains an "Outperform" rating for the company with a target price of RMB 156.55, representing a potential upside of 17% from the current price of RMB 132.90 [1][9]. Core Insights - The company achieved a revenue of RMB 10.30 billion in 2024, a decrease of 9.73% year-on-year, and a net profit attributable to shareholders of RMB 1.26 billion, down 36.08% [9][10]. - In Q1 2025, the company reported a revenue of RMB 2.48 billion, an increase of 5.42%, and a net profit of RMB 370 million, up 1.87% [9][10]. - The company is expected to have EPS of RMB 2.20 in 2025 and RMB 2.65 in 2026, with a new forecast for 2027 at RMB 3.18 [9][10]. Financial Summary - Revenue and Profit Forecasts: - 2023A: Revenue of RMB 11.41 billion, Net Profit of RMB 1.97 billion - 2024A: Revenue of RMB 10.30 billion, Net Profit of RMB 1.26 billion - 2025E: Revenue of RMB 12.44 billion, Net Profit of RMB 1.81 billion - 2026E: Revenue of RMB 14.97 billion, Net Profit of RMB 2.18 billion - 2027E: Revenue of RMB 17.99 billion, Net Profit of RMB 2.62 billion [2][5]. - Key Financial Ratios: - Net Asset Return Rate (ROE) is projected to be 6.3% in 2024 and 10.2% in 2027 [2][5]. - The Price-to-Earnings (P/E) ratio is expected to be 86.80 in 2024 and decrease to 41.84 by 2027 [2][5]. Market Position and Strategy - The company continues to increase its domestic market share, with a structural growth of over 3 percentage points year-on-year, particularly in high-end products [10][11]. - In 2024, the company achieved overseas revenue of RMB 2.27 billion, a growth of 35.07%, accounting for 22% of total revenue [11][12]. - The service revenue reached RMB 1.36 billion in 2024, representing a 26.80% increase and accounting for 13.16% of total revenue [12]. Conclusion - The report highlights the company's strong position in the medical imaging equipment sector, supported by ongoing domestic policy and international market expansion, justifying the "Outperform" rating and the target price increase [9][10][11].